JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB197347

Anti-CLCA4 antibody

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Polyclonal CLCA4 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CLCA4.

View Alternative Names

CaCC2, UNQ562/PRO1124, CLCA4, Calcium-activated chloride channel regulator 4, Calcium-activated chloride channel family member 4, Calcium-activated chloride channel protein 2, Chloride channel accessory 4, hCLCA4, CaCC-2, hCaCC-2

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CLCA4 antibody (AB197347)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CLCA4 antibody (AB197347)

Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue sections labeling CLCA4 with ab197347 at 1/10 dilution.

Western blot - Anti-CLCA4 antibody (AB197347)
  • WB

Supplier Data

Western blot - Anti-CLCA4 antibody (AB197347)

Gel : 8%SDS-PAGE.

All lanes:

Western blot - Anti-CLCA4 antibody (ab197347) at 1/200 dilution

All lanes:

293T cell lysate at 40 µg

Secondary

All lanes:

Anti-rabbit IgG at 1/8000 dilution

Predicted band size: 101 kDa

false

Exposure time: 30s

Western blot - Anti-CLCA4 antibody (AB197347)
  • WB

CiteAb

Western blot - Anti-CLCA4 antibody (AB197347)

CLCA4 western blot using anti-CLCA4 antibody ab197347. Publication image and figure legend from Liu, Z., Chen, M., et al., 2018, Aging (Albany NY), PubMed 30312171.

ab197347 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab197347 please see the product overview.

CLCA4expression was correlated with the expression of epithelial-mesenchymal transition (EMT) markers. (A) Serial sections of human HCC tissue were subjected to IHC staining with antibodies against CLCA4, E-cadherin, Vimentin and N-cadherin. In patient #1, low CLCA4 expression in HCC tissues was accompanied by the absence of E-cadherin and elevated Vimentin, N-cadherin. In patient #2, high CLCA4 expression was accompanied by elevated E-cadherin and the absence of Vimentin, N-cadherin. The scale bar represents 50 μm. (B) CLCA4 expression was positively associated with E-cadherin expression and negatively correlated with vimentin and N-cadherin expression. (C) Decreased expression of E-cadherin with increased expression of Vimentin and N-cadherin in CLCA4-silenced cells compared with the control cells. An opposite expression pattern of these genes was observed in CLCA4-transfected cells. (D) The mRNA of E-cadherin was down-regulated, while the vimentin and N-cadherin was up-regulated, when CLCA4 was silenced. And opposite expression was observed in CLCA4-transfected cells.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

Recombinant Fragment Protein within Human CLCA4. The exact immunogen used to generate this antibody is proprietary information.

Q14CN2

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/100 - 1/500", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/10 - 1/50", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May be involved in mediating calcium-activated chloride conductance.
See full target information CLCA4

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cells 14: PubMed39996749

2025

Transcriptomic Insights into Gas6-Induced Placental Dysfunction: Gene Targets for Preeclampsia Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew Jackson,Trenton M Gibson,Ethan Frank,Garrett Hill,Benjamin Davidson,Paul R Reynolds,Benjamin T Bikman,Brett E Pickett,Juan A Arroyo

European journal of histochemistry : EJH 66: PubMed35266369

2022

<em>miR-19a</em> targeting <em>CLCA4</em> to regulate the proliferation, migration, and invasion of colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Huiwen Li,Bo Huang

Cancer cell international 21:549 PubMed34663338

2021

Identification of key genes for HNSCC from public databases using bioinformatics analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Yuchu Ye,Jingyi Wang,Faya Liang,Pan Song,Xiaoqing Yan,Sangqing Wu,Xiaoming Huang,Ping Han

Molecular therapy. Nucleic acids 24:113-126 PubMed33738143

2021

Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xijuan Chen,Yingqiang Liu,Qinglan Zhang,Baoxing Liu,Yan Cheng,Yonglei Zhang,Yanan Sun,Junqi Liu

Medical science monitor : international medical jo 25:4176-4185 PubMed31164625

2019

Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Chen,Yang Liu,Cai-Jian Jiang,Yan-Min Chen,Hong Li,Qin-An Liu

Aging 10:2570-2584 PubMed30312171

2018

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao Liu,Mi Chen,Lin-Ka Xie,Ting Liu,Zhen-Wei Zou,Yong Li,Peng Chen,Xin Peng,Charlie Ma,Wen-Jie Zhang,Pin-Dong Li

Oncotarget 8:93001-93013 PubMed29190973

2017

CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Teng Hou,Lijie Zhou,Longwang Wang,Gallina Kazobinka,Xiaoping Zhang,Zhaohui Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com